Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 January 1993 | Volume 118 Issue 1 | Pages 37-39
Lactic acidosis has been reported in patients with the acquired immunodeficiency syndrome (AIDS) only in association with tissue hypoxia. From 1989 to 1991, seven patients with human immunodeficiency virus (HIV) infection who had lactic acidosis without obvious cause were evaluated. Nine normovolemic patients without acidosis or hypoxia served as controls. Findings in the patients included the following: pH, 7.22 ± 0.07; bicarbonate, 7.0 ± 2.4 mmol/L; and lactate, 14.3 ± 2.6 mmol/L. Patients and controls did not differ regarding cardiac index, Po2, oxygen extraction ratio, and systemic oxygen delivery or utilization. Four patients with AIDS died of overwhelming metabolic acidosis, but the three other patients were discharged from the hospital. Autopsy in the four patients who died showed no obvious cause for lactic acidosis. The normal oxygen delivery, utilization, and extraction suggest that increased hyperlactatemia occurred for reasons other than hypoxia. Thus, patients with AIDS but without hypoxia can develop severe lactic acidosis that is not necessarily fatal.
BRIEF REPORT
Lactic Acidosis Complicating the Acquired Immunodeficiency Syndrome
Lactic acidosis, characterized by metabolic acidosis and a blood lactate level higher than 5 mmol/L, is generally classified as either anaerobic (type A) or aerobic (type B) [1]. In type A lactic acidosis, tissue hypoxia and anaerobic metabolism have a definite clinical cause, such as pulmonary edema, cardiopulmonary arrest, or shock. Examples of type B lactic acidosis include that associated with malignancy, glycogen storage diseases, or certain myopathies, where tissue hypoxia is not apparent. In cases where the blood lactate level exceeds about 9 mmol/L, mortality may exceed 75% [2]. Patients with human immunodeficiency virus (HIV) infection may develop type A lactic acidosis associated with tissue hypoxia related to sepsis, shock, or cardiac arrest [3]. During a 2-year period, however, we encountered seven HIV-infected patients who developed severe lactic acidosis in the absence of hypoxemia or another obvious cause.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Between July 1989 and June 1991, seven patients with confirmed HIV infection (six with AIDS; one with AIDS-related complex) [4] developed lactic acidosis. The patients presented with the following symptom complexes: nausea, emesis, and anorexia with weight loss (n = 4); fever and malaise (n = 2); and tachypnea with dyspnea (n = 3) (Table 1). Metabolic acidosis was diagnosed in three patients at admission to the hospital because of dyspnea, whereas dyspnea or a decrease in the blood bicarbonate level led to evaluation of arterial blood gases in four other patients (Table 1). The control group included nine age-matched patients admitted to the same intensive care unit over the same interval who had placement of a pulmonary artery catheter [5] for close monitoring of volume status. When studied, all controls were normovolemic (normal cardiac output and pulmonary artery pressure), and none had metabolic acidosis, hypoxia, or clinical evidence of a mixed acid-base disorder. The cardiac output was determined by thermodilution [5]; the blood lactate level, oxygen delivery, and oxygen utilization were assessed as previously reported [6, 7]. Data are expressed as mean ±SD. The unpaired Student t-test was used for comparisons.
|
Results
|
|---|
|
|
|---|
In three patients, the cardiac index was 3.20 ± 0.21 L/min per m (2) body surface area (control value 3.19 ± 1.38 L/min per m2; P > 0.2) when the blood lactate level was 14.2 mmol/L. The systemic oxygen delivery was 938 ± 118 mL/min (controls, 1137 ± 490 mL/min; P > 0.2) and oxygen utilization was 211 ± 51 mL/min (controls, 213 ± 87 mL/min; P > 0.2). Thus, cardiac output, oxygen extraction, and both oxygen delivery and utilization were in the normal range [7, 8] and did not differ in controls (Figure 1).
|
Four patients died of cardiovascular collapse secondary to progressive metabolic acidosis (see Table 1). In all four, the arterial pH fell below 6.85 and the lactate level was higher than 15 mmol/L before death. However, in the other three patients, arterial pH and blood levels of lactate did not change substantially during hospitalization, and all were discharged in a lucid and ambulatory state. Within 15 months, all had died of other complications of AIDS (see Table 1).
Discussion
|
|---|
|
|
|---|
The disorder in the patients resembled adult Reye syndrome, in that type B lactic acidosis was associated with a probable infectious cause [9]. Increased production of lactate may also have been associated with a myopathy related to zidovudine therapy. Such a myopathy can cause a decrease of muscle respiratory chain capacity in some patients with AIDS [10]. Lactic acidosis was a major comorbid event in four patients, but the other three survived an average of 32 weeks, suggesting a heterogeneous cause.
This study was presented in part at the 23rd Annual Meeting, American Society of Nephrology, November 1991, Baltimore, Maryland.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Cohen RD. The metabolic background to acid-base homeostasis and some of its disorders: lactic acidosis. In: Cohen RD, Lewis B, Alberti KG, Denman AM, eds. The Metabolic and Molecular Basis of Acquired Disease. Philadelphia: W.B. Saunders; 1990:981-8.
2. Peretz DL, Scott HM, Duff J. The significance of lactic acidemia in the shock syndrome. Ann NY Acad Sci. 1965; 119:1133-41.
3. Madias NE. Lactic acidosis. Kidney Int. 1986; 29:752-74.
4. Andrulis DP, Weslowski VB, Hintz E, Spolarich AW. Comparisons of hospital care for patients with AIDS and other HIV-related conditions. JAMA. 1992; 267:2482-6.
5. Ganz W, Donose R, Marcus HS, Forrester JS, Swan HJ. A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol. 1971; 27:392-6.
6. Arieff AI, Graf H. Pathophysiology of type A hypoxic lactic acidosis in dogs. Am J Physiol. 1987; 253:E271-6.
7. Bersin RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med. 1989; 87:7-14.
8. Gutierrez G, Bismar H, Dantzker DR, Silva N. Comparison of gastric intramucosal pH with measures of oxygen transport and consumption in critically ill patients. Crit Care Med. 1992; 20:451-7.
9. Aiyathurai JE, Wong HB, Quak SH, Jacob E, Chio LF, Sothy SP. The significance of type B hyperlactataemia in infective encephalopathy. Ann Acad Med Singapore. 1983; 12:115-25.
10. Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 1991; 29:606-14.
This article has been cited by other articles:
![]() |
J. S. Berns and N. Kasbekar Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 117 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Fall and H. M. Szerlip Lactic Acidosis: From Sour Milk to Septic Shock J Intensive Care Med, September 1, 2005; 20(5): 255 - 271. [Abstract] [PDF] |
||||
![]() |
C. L. Cherry and S. L. Wesselingh Nucleoside analogues and HIV: the combined cost to mitochondria J. Antimicrob. Chemother., May 1, 2003; 51(5): 1091 - 1093. [Full Text] [PDF] |
||||
![]() |
W. Lewis Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H1 - H9. [Full Text] [PDF] |
||||
![]() |
N P Smith and A L Pozniak The changing face of HIV Imaging, February 1, 2002; 14(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Pao, C Watson, B Peters, S B Lucas, and R F Miller Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors Sex. Transm. Inf., October 1, 2001; 77(5): 381 - 384. [Full Text] [PDF] |
||||
![]() |
NRTI-Associated Mitochondrial Toxicity AIDS Clinical Care, May 1, 2001; 2001(501): 7 - 7. [Full Text] |
||||
![]() |
K. D. Miller, M. Cameron, L. V. Wood, M. C. Dalakas, and J. A. Kovacs Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases Ann Intern Med, August 1, 2000; 133(3): 192 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chodock, E. Mylonakis, D. Shemin, V. Runarsdottir, P. Yodice, R. Renzi, K. Tashima, C. Towe, and J. D. Rich Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis—role of haemodialysis treatment Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2484 - 2486. [Full Text] [PDF] |
||||
![]() |
B. Allaouchiche, F. Duflo, L. Cotte, L. Mathon, and D. Chassard Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy J. Antimicrob. Chemother., July 1, 1999; 44(1): 137 - 138. [Full Text] [PDF] |
||||
![]() |
R. McKenzie, M. W. Fried, R. Sallie, H. Conjeevaram, A. M. Di Bisceglie, Y. Park, B. Savarese, D. Kleiner, M. Tsokos, C. Luciano, et al. Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B N. Engl. J. Med., October 26, 1995; 333(17): 1099 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Lee Drug-Induced Hepatotoxicity N. Engl. J. Med., October 26, 1995; 333(17): 1118 - 1127. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||